Login / Signup

Comparison Between Ranibizumab Biosimilar, Innovator Ranibizumab and Bevacizumab in a Real-World Situation.

Dhanashree RatraKrishnakanta RoySneha GiridharSushant Madaannull null
Published in: Ophthalmology and therapy (2021)
Biosimilar ranibizumab is comparable to innovator ranibizumab and bevacizumab in efficacy and safety.
Keyphrases
  • diabetic retinopathy
  • age related macular degeneration
  • metastatic colorectal cancer
  • optical coherence tomography